Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any other words.
Options:
a.) CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1
b.) CC(C)NCC(O)COc1cccc2[nH]ccc12
c.) NC(=O)CN1CC(O)CC1=O
d.) CCCCCCCCC/C=C/C=C/C(=O)CCC(=O)NC1[C@H](C(O)CO)O[C@H](Nc2ncnc3nc[nH]c23)[C@H](O)[C@@H]1O
e.) Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1
Answer: d
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
(5E,7E)-N-[(2R,4R,5R,6S)-2-(1,2-dihydroxyethyl)-4,5-dihydroxy-6-(7H-purin-6-ylamino)oxan-3-yl]-4-oxoheptadeca-5,7-dienamide